Trial Profile
The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms SAFER
- 27 Sep 2019 Status changed from active, no longer recruiting to completed.
- 14 Jun 2019 Planned End Date changed from 1 Apr 2019 to 1 Jul 2019.
- 14 Jun 2019 Planned primary completion date changed from 1 Apr 2019 to 1 Jul 2019.